(Total Views: 476)
Posted On: 03/14/2021 3:38:43 PM
Post# of 153964
In some ways, it would have been better if CD12 was a total failure.
We could have washed our hands, said we tried our best, and refocused on HIV, NASH and cancer.
But because leronlimab does have a benefit for the worst-suffering COVID patients, we CAN'T give up now. It would be morally wrong to walk away now. We CAN save people who are out of options.
And I think that's a good thing, even though it's harder on the wallet, and extremely frustrating for an investor.
I think Nader and everyone else looks at it those way too. You can't give up when you have them ability to help people, PPS be damned.
We could have washed our hands, said we tried our best, and refocused on HIV, NASH and cancer.
But because leronlimab does have a benefit for the worst-suffering COVID patients, we CAN'T give up now. It would be morally wrong to walk away now. We CAN save people who are out of options.
And I think that's a good thing, even though it's harder on the wallet, and extremely frustrating for an investor.
I think Nader and everyone else looks at it those way too. You can't give up when you have them ability to help people, PPS be damned.
(6)
(0)
